期刊文献+

HPV与宫颈癌的关系及其检测在临床应用的进展 被引量:12

Progress in research on relationship between HPV and cervical cancer and application of detection of HPV DNA in clinic
暂未订购
导出
摘要 宫颈癌在世界范围内发病率位居女性恶性肿瘤的第2位。高危型人乳头瘤病毒生殖道持续感染被认为是引起宫颈癌前病变——宫颈上皮内瘤变及宫颈癌的主要病因。宫颈癌存在着一个较长的、可逆转的癌前病变期,故对宫颈癌的筛查及对宫颈上皮内瘤变的治疗处理一直受到关注。该文就人乳头瘤病毒导致宫颈癌的机制及其检测的临床应用等研究进行综述。 Cervical cancer remains the second most common malignancy in women worldwide. The persistant infection of highrisk genotypes of human papilloma virus(HRHPV) in the genital tract is thought the main cause of precancerous lesion—cervical intraepithelial neoplasia(CIN) and cervical cancer. Cervical cancer has a long reversible precancerous stage, so the screening of cervical cancer and treatment of CIN have attracted more attention for a long time. This article reviewed the major mechanisms that HPV causes cervical cancer and clinical application of detection of HPV DNA in cervical secretions.
作者 刘娜 王英红
出处 《中国妇幼健康研究》 2010年第2期253-255,共3页 Chinese Journal of Woman and Child Health Research
基金 【基金项目]石河子大学医学院第一附属医院院级科研资助项目(YL2008-Y002)
关键词 人乳头瘤病毒 宫颈癌 宫颈上皮内瘤变 第2代杂交捕获试验 human papillomavirus (HPV) cervical cancer cervical intraepithelial neoplasia (CIN) hybrid capture 2 (HC2)
  • 相关文献

参考文献20

  • 1Van Tine B A, Dao L D, Wu S Y, et al. Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning [ J ]. Proc Natl Acad Sci USA,2004, 101 (12) :4030-4035.
  • 2Jung W W, Chun T, Sul D, et al. Strategies against human papillomavirus infection and cervical cancer[ J]. J Microbiol,2004, 42 (4) :255 -266.
  • 3Jenkins D. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention [ J ]. Gynecol Oncol, 2008, 110(3) :18-25.
  • 4Nishimura A, Nakahara T, Ueno T, et al. Requirement of E7 on protein for viability of Hela ceils[ J]. Microbes Infect,2006,8 (4) : 984-993.
  • 5KimY T, Zhao M. Aberrant cell cycle regulation in cervical carcinoma[ J]. Yousei Med J,2005,46(5 ) :597-613.
  • 6Arias P H, Peyton C L, Joste N E, et al. Human Papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer[ J]. J Clin Microbiol,2006,44 ( 5 ) : 1755-1762.
  • 7De Wilde J, Wilting S M, Meijer C J, et al. Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer[ J ]. Int J Cancer, 2008,122(4) :877-888.
  • 8Kang Y H, Lee K A, Ryu C J, et al. Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells[ J]. Cancer Leu,2006,237 (1) :33-44.
  • 9Deng W, Tsao S W, Kwok Y K, et al. Transforming growth factor betal promotes chromosomal instability in human papilIomavims 16 E6 E7-infected cervical epithelial cells [ J ]. Cancer Res, 2008,68 ( 17 ) :7200-7209.
  • 10Naucler P, Ryd W, Tomberg S, et'al. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening[ J]. J Natl Cancer Inst,2009,101 (1) :88-99.

同被引文献87

引证文献12

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部